Functional sites of chemically modified tetracyclines: Inhibition of the oxidative activation of human neutrophil and chicken osteoclast pro-matrix metalloproteinases

Journal of Rheumatology

Volumn 25, Issue 5, 1998, Pages 975-982

  Sorsa, Timo ^a   Ramamurthy, Nungavaram S ^b   Vernillo, Anthony T ^c   Zhang, Xia ^b   Konttinen, Yrjö T ^a   Rifkin, Barry R ^c   Golub, Lorne M ^b  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^b STONY BROOK UNIVERSITY   (United States)

^c NEW YORK UNIVERSITY   (United States)

Author keywords

Collagenase; Gelatinase; Hypochlorous acid; Osteoclast; Tetracycline

Indexed keywords

HYPOCHLORITE SODIUM; MERCURY DERIVATIVE; NEUTROPHIL COLLAGENASE;

ANIMAL CELL; ARTICLE; BONE DESTRUCTION; CHICKEN; DRUG EFFECT; ENZYME INHIBITION; IMMUNOREGULATION; LEUKOCYTE ACTIVATION; NONHUMAN; OSTEOCLAST; OXIDATIVE STRESS; PRIORITY JOURNAL;

ANIMALS; CHICKENS; COLLAGENASES; ENZYME ACTIVATION; GELATINASES; HUMANS; HYPOCHLOROUS ACID; MATRIX METALLOPROTEINASE 8; MATRIX METALLOPROTEINASE 9; METALLOENDOPEPTIDASES; NEUTROPHILS; OSTEOCLASTS; TETRACYCLINES;

EID: 0031946442     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (64)

1. Woessner FJ Jr. The family of matrix metalloproteinases. Ann NY Acad Sci 1994;732:11-21.
2. Greenwald RA. Treatment of destructive arthritis with MMP inhibitors. Potential role of tetracyclines. Ann NY Acad Sci 1994;732:181-98.
3. Brandt KD. Insights into the natural history of osteoarthritis provided by the cruciate-deficient dog. An animal model of osteoarthritis. Ann NY Acad Sci 1994;732:199-205.
4. Brinkenhoff CE. Joint destruction in arthritis. Arthritis Rheum 1991;34:1073-5.
5. Birkedal-Hansen H. Role of matrix metalloproteinases in human diseases. J Periodontol 1993;64:474-84.
6. Weiss SJ, Peppin G, Ortiz X, Ragsdale C, Test ST. Oxidative autoactivation of latent collagenase by human neutrophils. Science 1985;277:747-9.
7. Weiss SJ. Tissue destruction by neutrophils. N Engl J Med 1989;320:365-76.
8. Sorsa T, Saari H, Konttinen YT, Uitto V-J, Lindy S. Human neutrophil collagenase and oxygen derived free radicals. N Engl J Med 1989;321:327-8.
9. Sorsa T, Saari HT, Konttinen YT, Suomalainen K, Lindy S, Uitto V-J. Non-proteolytic activation of latent human neutrophil collagenase and its role in matrix destruction in periodontal disease. Int J Tissue React 1989;11:153-9.
10. Burkhardt H, Bertling WM. The role of oxygen radicals in cartilage destruction in rheumatoid arthritis. In: Kang A, Nimni M, editors. Collagen. Vol. 5. Pathobiochemistry. Boca Raton, FL, USA: CRC Press, 1992:218-34.
11. Stricklin GP, Hordal JR. Oxidant-mediated inactivation of TIMP. Matrix 1992; Suppl 1:325-6.
12. Wlaschek M, Briviba K, Stricklin GP, Helmut S, Scharffetter-Kochank K. Singlet oxygen may mediate the ultraviolet A-induced synthesis of interstitial collagenase. J Invest Dermat 1995;104: 194-8.
13. Golub LM, Lee HM, Lehrer G, et al. Minocycline reduces gingival collagenolytic acitivity during diabetes: preliminary observations and a proposed new mechanism of action. J Periodontal Res 1983;16:516-26.
14. Golub LM, Ramamurthy NS, McNamara TF, et al. Tetracyclines inhibit tissue collagenase activity: a new mechanism in the treatment of periodontal disease. J Periodontal Res 1984;10:651-5.
15. Golub LM, Wolff M, Lee HM, et al. Further evidence that tetracyclines inhibit collagenase activity in human crevicular fluid and from other mammalian sources. J Periodontal Res 1985; 20:12-23.
16. Golub LM, Suomalainen K, Sorsa T. Host modulation with tetracyclines and their chemically-modified non-antimicrobial derivatives. Curr Opinion Dent 1992;2:80-90.
17. Golub LM, Evans RT, McNamara TF, Lee HM, Ramamurthy NS. A non-antimicrobial tetracycline inhibits gingival matrix metalloproteinase and bone loss in Porphyromonas gingivalis-induced periodontitis in rats. Ann NY Acad Sci 1994;732:96-111.
18. Golub LM, McNamara TF, D'Angelo G, Greenwald RA, Ramamurthy NS. A non-antibacterial chemically-modified tetracycline inhibits mammalian collagenase activity. J Dent Res 1987;66:1310-4.
19. Greenwald RA, Golub LM, Lavietes B, Moak S, Ramamurthy NS. Minocycline inhibits rheumatoid synovial collagenase in vivo and in vitro. J Rheumatol 1987;14:23-8.
20. Suomalainen K, Sorsa T, Golub LM, et al. Specificity of the anticollagenase action of tetracyclines: relevance to their anti-inflammatory potential. Antimicrobial Agents Chemother 1992;36:227-9.
21. Sorsa T, Ding Y, Salo T, et al. Effect of tetracyclines on neutrophil gingival and salivary collagenases. A functional and Western-blot assessment with special reference to their cellular sources in periodontal diseases. Ann NY Acad Sci 1994;732:112-31.
22. Maragoudakis ME, Peristeris P, Missirlis E, Aletras A, Andriopoulou P, Haralabopoulos E. Inhibition of angiogenesis by anthracyclines and titanocene dichloride. Ann NY Acad Sci 1994;732:280-93.
23. Lauhio A, Sorsa T, Lindy O, et al. The anticollagenolytic potential of lymecycline in the long-term treatment of reactive arthritis. Arthritis Rheum 1992;35:195-8.
24. Ramamurthy NS, Vernillo AT, Rifkin B, et al. Reactive oxygen species activate and tetracyclines inhibit rat osteoblast collagenase. J Bone Miner Res 1993;8:1247-53.
25. Uitto V-J, Firth JD, Nip L, Golub LM. Doxycycline and chemically modified tetracyclines inhibit gelatinase A (MMP-2) gene expression in human skin keratinocytes. Ann NY Acad Sci 1994;732:141-51.
26. Hanemeeijer R, Visser H, Koolwik P, et al. Down-regulation of gelatinase B activity and synthesis by doxycycline in human endothelial cells [abstract]. J Dent Res 1996;75:107.
27. 1-antitrypsin from human neutrophil collagenase and gelatinase. Antimicrob Agents Chemother 1993;37:592-4.
28. Mallaya SK, Hall IE, Lee H-M, Roemer EJ, Simon SR, Golub LM. Interaction of matrix metalloproteinases with serine proteinase inhibitors. New potential roles for matrix metalloproteinase inhibitors. Ann NY Acad Sci 1994;732:303-14.
29. 1-proteinase inhibitor in gingival crevicular fluid of humans with adult periodontitis: serpinolytic inhibition of doxycycline. J Periodont Res 1997; 32:9-19.
30. Golub LM, Ramamurthy NS, McNamara TF, Greenwald RA, Rifkin BR. Tetracyclines inhibit connective tissue breakdown. New therapeutic implications for an old family of drugs. Crit Rev Oral Biol Med 1991;2:297-322.
31. Greenwald RA, Moak SA, Ramamurthy NS, Golub LM. Tetracyclines suppress matrix metalloproteinase activity in adjuvant arthritis and in combination with flurbiprofen, ameliorate bone damage. J Rheumatol 1992;19:927-38.
32. Sorsa T, Uitto V-J, Suomalainen K, Vauhkonen M, Lindy S. Comparison of interstitial collagenases from human gingival sulcular fluid and polymorphonuclear leukocytes. J Periodont Res 1988;23:386-93.
33. Konttinen YT, Lindy O, Kemppinen P, et al. Collagenase reserves in polymorphonuclear neutrophil leukocytes from synovial fluid and peripheral blood of patients with rheumatoid arthritis. Matrix 1991;11:296-301.
34. Konttinen YT, Lindy O, Suomalainen K, et al. Substrate specificity and activation mechanisms of collagenase from human rheumatoid synovium. Matrix 1991;11:395-403.
35. 1-antitrypsin. Biochem J 1990;270:809-14.
36. Collin-Osdoby P, Ourster MJ, Webber D, Osdoby P. Osteoclast-specific monoclonal antibodies coupled to magnetic beads provide a rapid and efficient method of purifying avian osteoclasts. J Bone Miner Res 1991;6:1353-6.
37. Rifkin BR, Vernillo AT, Golub LM, Ramamurthy NS. Modulation of bone resorption by tetracyclines. Ann NY Acad Sci 1994;732: 165-80.
38. McCroskery PA, Richards JF, Harris ED. Purification and characterization of a collagenase extracted from rabbit tumors. Biochem J 1975;152:131-42.
39. Brown P, Leuan A, Marguiles I, Liotta L, Stettler-Stevenson D. Independent expression and cellular processing of Mr 72,000 type IV collagenase and interstitial collagenase in human tumorigenic cell line. Cancer Res 1990;50:6184-91.
40. Seltzer JL, Eschbach ML, Winberg JO, Bauer EA, Eisen AZ, Weingarten H. Eriochrome black T inhibition of human skin collagenase, but not gelatinase, using both protein and synthetic substrates. Coll Rel Res 1981;7:399-407.
41. Overall CM, Sodek J. Initial characterization of neutral metalloproteinase, active on native 3/4-collagen fragments, synthesized by ROS 17/2.8 osteoblastic cells, periodontal fibroblasts, and identified in gingival crevicular fluid. J Dent Res 1987;66:1271-82.
42. Yu LP Jr, Burr DB, Brandt KD, O'Connor BL, Rubinow A, Albrecht M. Effects of oral doxycycline administration on histomorphometry and dynamics of subchondral bone in a canine model of osteoarthritis. J Rheumatol 1996;23:137-42.
43. Greenwald RA, Chowdhury MH, Moak SA, Wang H, Crossley H, Caterson B. Long-term doxycycline treatment inhibits histologic and immunologic features of spontaneous osteoarthritis in guinea pigs. Trans Orthop Res Soc 1994; 19:473.
44. Caterson B, Hughes CE, Roughley P, Mort JS. Anabolic and catabolic markers of proteoglycan metabolism in osteoarthritis [review]. Acta Orthop Scand 1995; Suppl 266:121-4.
45. Vernillo AT, Ramamurthy NS, Golub LM, Greenwald RA, Rifkin BR. Tetracyclines as inhibitors of bone resorption. In: Cohen M Jr, Baum BJ, editors. Studies in stomatology and craniofacial biology. Amsterdam: IOS Press, 1997:499-522.
46. Lauhio A, Salo T, Ding Y, et al. In vivo inhibition of human neutrophil collagenase (MMP-8) activity during long-term combination therapy of doxycycline and NSAID in acute reactive arthritis. Clin Exp Immunol 1994;98:21-8.
47. Lauhio A, Salo T, Tjaderhane L, Lahdevirta J, Golub LM, Sorsa T. Tetracyclines in the treatment of rheumatoid arthritis. Lancet 1995;346:645-6.
48. Smith GN, Brandt KD, Hasty KA. Procollagenase is reduced to inactive fragments upon activation in the presence of doxycycline. Ann NY Acad Sci 1994;732:436-8.
49. Smith GN, Brandt KP, Hasty KA. Activation of recombinant human neutrophil pro-collagenase in the presence of doxycycline results in fragmentation of the enzyme and loss of enzyme activity. Arthritis Rheum 1996;39:235-44.
50. Smith GN, Brandt K, Mickler EA, Hasty KA. Inhibition of recombinant human neutrophil collagenase by doxycycline is pH dependent. J Rheumatol 1997;24:1769-73.
51. Ryan ME, Ramamurthy NS, Golub LM. Matrix metalloproteinases and their inhibition in periodontal treatment. Curr Opin Periodontol 1995;3:85-96.
52. Silverton S. Osteoclast radicals. J Cell Biochem 1994;56:367-73.
53. Reponen P, Sahlberg C, Munaut C, Thesleff I, Tryggvason K. High expression of 92 kD type IV collagenase (gelatinase B) in the osteoclast lineage during mouse development. J Cell Biol 1994;124:1091-102.
54. Fuller K, Chambers TJ. Localization of mRNA for collagenase in osteocytic, bone surface and chondrocytic cells but not osteoclasts. J Cell Sci 1995;108:2221-30.
55. Gomisruth FX, Gohlke U, Betz M, et al. The helping hand collagenase-3 (MMP-13)-2.7 angstrom crystal structure of its C-terminal haemopexin-like domain. J Mol Biol 1996;264:556-66.
56. Aimes RT, Quigley IP. Matrix metalloproteinase-2 is an interstitial collagenase. J Biol Chem 1995;270:5872-6.
57. Sorsa T, Konttinen YT, Lindy O, et al. Collagenase in synovitis of rheumatoid arthritis. Semin Arthritis Rheum 1992;22:44-53.
58. Welgus HG, Jeffrey JJ, Eisen AL. The collagen substrate specificity of human skin fibroblast collagenase. J Biol Chem 1981;256: 9511-8.
59. Freije JMP, Diez-Itza I, Balbin M, et al. Molecular cloning and expression of collagenase-3, a novel human matrix metalloproteinase produced by breast carcinomas. J Biol Chem 1994;269:16766-73.
60. Knauper V, Lopez-Otin C, Smith B, Knight G, Murphy G. Biochemical characterization of human collagenase-3. J Biol Chem 1996;271:1544-50.
61. Mitchell PG, Magna HA, Reeves LM, et al. Cloning, expression and type II collagenolytic activity of matrix metalloproteinase-13 from human osteoarthritic cartilage. J Clin Invest 1996;97:761-8.
62. Stahle-Backdahl M, Sandstedt B, Bruce K, et al. Collagenase-3 (MMP-13) is expressed during human fetal ossification and re-expressed in postnatal bone remodelling and in rheumatoid arthritis. Lab Invest 1997;76:717-27.
63. Yu Z, Ramamurthy NS, Leung M, Chang KM, McNamara TF, Golub LM. Chemically modified tetracycline normalizes collagen metabolism in diabetic rats: a dose-response study. J Periodont Res 1994;28:420-8.
64. Greenwald RA, Golub LM, Ramamurthy NS, Chowdhury M, Moak SA, Sorsa T. In vitro sensitivity of the three mammalian collagenases to tetracycline inhibition: relationship to bone and cartilage degradation. Bone 1998;22:33-8.